Finding 502746 (2023-008)

Significant Deficiency Repeat Finding
Requirement
N
Questioned Costs
-
Year
2023
Accepted
2024-10-15
Audit: 324814
Organization: Martin University (IN)

AI Summary

  • Core Issue: The university failed to conduct a required risk assessment related to the Gramm-Leach-Bliley Act, leaving student financial aid information potentially vulnerable.
  • Impacted Requirements: Compliance with 2 CFR section 200.303(a) and 16 CFR 314.4(b) regarding internal controls and safeguarding sensitive data.
  • Recommended Follow-Up: Engage a third party or conduct the necessary risk assessment for the two incomplete areas and document safeguards for identified risks.

Finding Text

2023-008: Special Tests and Provisions – The Gramm-Leach-Bliley Act (GLBA) Federal Agency: Department of Education Federal Program Title: Student Financial Aid Cluster Assistance Listing Number: 84.007, 84.033, 84.063, 84.268 Award Number and Year: P007A215801 (March 25, 2021 - August 31, 2027), P033A215801(July 1, 2021 - August 31, 2027), P063P213807(March 23, 2021 - August 31, 2027), P268K223807(January 1, 2021 - July 31, 2043) Award Period: July 1, 2022 – June 30, 2023 Type of Finding: Significant Deficiency in Internal Control Over Compliance, Other Matters Criteria or Specific Requirement: Internal Control – Per 2 CFR section 200.303(a), a non-Federal entity must: Establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Compliance- The Gramm-Leach-Bliley Act (Public Law 106-102) requires financial institutions to explain their information-sharing practices to their customers and to safeguard sensitive data. (16 CFR 314) The Federal Trade Commission considers Title IV-eligible institutions that participate in Title IV Educational Assistance Programs as “financial institutions” and subject to the Gramm-Leach-Bliley Act (16 CFR 313.3(k)(2)(vi). Condition: Under an institution’s Program Participation Agreement with the Department of Education and the Gramm-Leach-Bliley Act, schools must protect student financial aid information, with particular attention to information provided to institutions by the Department or otherwise obtained in support of the administration of the federal student financial aid programs. Questioned Costs: None Context: During our audit procedures, it was noted that the university did not conduct a risk assessment that addresses (2) and (3) of the 3 areas noted in 16 CFR 314.4 (b) which are (1) Employee training and management; (2) Information systems, including network and software design, as well as information processing, storage, transmission and disposal; and (3) Detecting, preventing and responding to attacks, intrusions, or other systems failures and document safeguards for identified risks. Cause: The University experienced turnover in the department responsible for this process. Effect: The student personal information could be vulnerable. Repeat Finding: Yes – 2022-009. Recommendation: We recommend the University engage a third party or perform the risk assessment for the two areas required by the Gramm-Leach-Bliley Act that have not been completed and documented and ensure that there are documented safeguards for identified risks. Views of Responsible Officials: There is no disagreement with the audit finding.

Categories

Special Tests & Provisions Student Financial Aid Subrecipient Monitoring Significant Deficiency Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 502718 2023-001
    Material Weakness Repeat
  • 502719 2023-002
    Material Weakness Repeat
  • 502720 2023-003
    Significant Deficiency Repeat
  • 502721 2023-004
    Significant Deficiency Repeat
  • 502722 2023-005
    Significant Deficiency Repeat
  • 502723 2023-006
    Significant Deficiency Repeat
  • 502724 2023-008
    Significant Deficiency Repeat
  • 502725 2023-001
    Material Weakness Repeat
  • 502726 2023-002
    Material Weakness Repeat
  • 502727 2023-003
    Significant Deficiency Repeat
  • 502728 2023-004
    Significant Deficiency Repeat
  • 502729 2023-005
    Significant Deficiency Repeat
  • 502730 2023-006
    Significant Deficiency Repeat
  • 502731 2023-008
    Significant Deficiency Repeat
  • 502732 2023-001
    Material Weakness Repeat
  • 502733 2023-002
    Material Weakness Repeat
  • 502734 2023-003
    Significant Deficiency Repeat
  • 502735 2023-004
    Significant Deficiency Repeat
  • 502736 2023-005
    Significant Deficiency Repeat
  • 502737 2023-006
    Significant Deficiency Repeat
  • 502738 2023-007
    Significant Deficiency Repeat
  • 502739 2023-008
    Significant Deficiency Repeat
  • 502740 2023-001
    Material Weakness Repeat
  • 502741 2023-002
    Material Weakness Repeat
  • 502742 2023-003
    Significant Deficiency Repeat
  • 502743 2023-004
    Significant Deficiency Repeat
  • 502744 2023-005
    Significant Deficiency Repeat
  • 502745 2023-006
    Significant Deficiency Repeat
  • 1079160 2023-001
    Material Weakness Repeat
  • 1079161 2023-002
    Material Weakness Repeat
  • 1079162 2023-003
    Significant Deficiency Repeat
  • 1079163 2023-004
    Significant Deficiency Repeat
  • 1079164 2023-005
    Significant Deficiency Repeat
  • 1079165 2023-006
    Significant Deficiency Repeat
  • 1079166 2023-008
    Significant Deficiency Repeat
  • 1079167 2023-001
    Material Weakness Repeat
  • 1079168 2023-002
    Material Weakness Repeat
  • 1079169 2023-003
    Significant Deficiency Repeat
  • 1079170 2023-004
    Significant Deficiency Repeat
  • 1079171 2023-005
    Significant Deficiency Repeat
  • 1079172 2023-006
    Significant Deficiency Repeat
  • 1079173 2023-008
    Significant Deficiency Repeat
  • 1079174 2023-001
    Material Weakness Repeat
  • 1079175 2023-002
    Material Weakness Repeat
  • 1079176 2023-003
    Significant Deficiency Repeat
  • 1079177 2023-004
    Significant Deficiency Repeat
  • 1079178 2023-005
    Significant Deficiency Repeat
  • 1079179 2023-006
    Significant Deficiency Repeat
  • 1079180 2023-007
    Significant Deficiency Repeat
  • 1079181 2023-008
    Significant Deficiency Repeat
  • 1079182 2023-001
    Material Weakness Repeat
  • 1079183 2023-002
    Material Weakness Repeat
  • 1079184 2023-003
    Significant Deficiency Repeat
  • 1079185 2023-004
    Significant Deficiency Repeat
  • 1079186 2023-005
    Significant Deficiency Repeat
  • 1079187 2023-006
    Significant Deficiency Repeat
  • 1079188 2023-008
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
84.268 Federal Direct Student Loans $1.18M
84.063 Federal Pell Grant Program $482,460
84.007 Federal Supplemental Educational Opportunity Grants $25,631
84.033 Federal Work-Study Program $25,000